Residential College | false |
Status | 已發表Published |
Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion | |
Liu,Xiaoming1; Xie,Weiying1; Liu,Pichu2; Duan,Manlin1; Jia,Zhen1; Li,Wei1; Xu,Jianguo1 | |
2006-04-04 | |
Source Publication | Life Sciences |
ISSN | 00243205 |
Volume | 78Issue:19Pages:2255-2264 |
Abstract | Erythropoietin (EPO), originally known for its role in stimulation of erythropoiesis, has recently been shown to have a dramatic protective effect in animal models of myocardial ischemia-reperfusion (I-R) injury. However, the precise mechanisms remain unclear. We tried to study the anti-inflammatory properties of recombinant human erythropoietin (rhEPO) using an in vivo myocardial I-R rat model, which was established by 30 min ligation of left descending coronary and 3 h reperfusion. rhEPO or saline solution was intraperitoneally injected 24 h before I-R insult. The infarct size was measured by triphenyltetrazolium chloride (TTC)-Evans blue technique. Myeloperoxidase (MPO) activity and tissue neutrophil infiltration were studied. Ultrastructural organizations were observed and semiquantitatively evaluated. Tumor necrosis-alpha (TNF-α), interleukin-6 (IL-6), and IL-10 concentrations of left ventricle were analyzed by enzyme-linked immunosorbance assays; intercellular adhesion molecule-1 (ICAM-1) by reverse-transcription polymerase chain reaction; and nuclear factor-kappa B (NF-κB) and activator protein 1 (AP-1) by electrophoretic mobility shift assay, respectively. We found that a single bolus injection of 5000 units/kg of rhEPO 24 h before insult remarkably reduced infarct size and neutrophil infiltration. It greatly attenuated I-R-induced NF-κB and AP-1 activation with decreased TNF-α, IL-6, and ICAM-1 production, but enhanced IL-10 production. In conclusion, the cardioprotection of EPO may be due in part to the suppression of the inflammatory response via down-regulation of NF-κB and AP-1 induced by I-R. IL-10 was also suggested to play a protective role through another independent mechanism involved in cardioprotection of rhEPO. © 2005 Elsevier Inc. All rights reserved. |
Keyword | Ap-1 Erythropoietin Il-10 Ischemia-reperfusion Nf-κb |
DOI | 10.1016/j.lfs.2005.09.053 |
URL | View the original |
Language | 英語English |
WOS ID | WOS:000236718800014 |
Scopus ID | 2-s2.0-33645210680 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | Personal research not belonging to the institution |
Affiliation | 1.Department of Anesthesiology,Jinling Hospital,Nanjing University,,China 2.Department of Surgery,Jinling Hospital,Nanjing University,,China |
Recommended Citation GB/T 7714 | Liu,Xiaoming,Xie,Weiying,Liu,Pichu,et al. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion[J]. Life Sciences,2006,78(19):2255-2264. |
APA | Liu,Xiaoming,Xie,Weiying,Liu,Pichu,Duan,Manlin,Jia,Zhen,Li,Wei,&Xu,Jianguo.(2006).Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion.Life Sciences,78(19),2255-2264. |
MLA | Liu,Xiaoming,et al."Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion".Life Sciences 78.19(2006):2255-2264. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment